| Literature DB >> 21948256 |
Kumar Vivek1, Moiz M Mustafa, Eduardo Rodriguez, Robert R Redfield, Ronald F Parsons, Susan Rostami, Thi-Sau Migone, Michael P Cancro, Ali Naji, Hooman Noorchashm.
Abstract
Transplantation tolerance remains an elusive goal as B-cell-initiated chronic humoral rejection evades current immunosuppression. B-cell-directed therapy is thus emerging as a key component in achieving transplantation tolerance and long-term graft survival. Here, we propose strategies of B-cell repertoire remodeling to achieve humoral unresponsiveness to donor antigens with implementation of fundamental B-cell immunobiology and use of newly developed B-cell-directed agents.Entities:
Mesh:
Year: 2011 PMID: 21948256 DOI: 10.1007/s12026-011-8246-6
Source DB: PubMed Journal: Immunol Res ISSN: 0257-277X Impact factor: 2.829